Amneal Pharmaceuticals, Inc. (AMRX)
$18.90-3.42%Close
BUYBEAR · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $6.0B
- Beta
- 1.22
- P/E (TTM)
- 37.99
- Short % float
- 6.90%
- Days to cover
- 3.1
- SI change
- -0.1%
- 1W
- -3.82%
- 1M
- +13.51%
- vs SPY 1W
- -3.68%
- vs SPY 1M
- +11.01%
Industry peers
FMP comparable companies · ranked by market cap
- TEVABUYTeva Pharmaceutical Industries Limited$47.9BBULLQ 13$41.10-1.28%
- VTRSBUYViatris Inc.$20.5BBULLQ 5$17.64+1.10%
- RDYBUYDr. Reddy's Laboratories Limited$10.4BRECOVERYQ 16$12.48-0.16%
- INDVSELLIndivior Pharmaceuticals Inc$4.5BRECOVERYQ 20$35.83-3.56%
- BHCSELLBausch Health Companies Inc.$2.3BRECOVERYQ 2$6.04+0.00%
- PRGOBUYPerrigo Company plc$2.1BRECOVERYQ 4$15.06+3.77%
- ANIPSELLANI Pharmaceuticals, Inc.$1.7BRECOVERYQ 9$73.89-0.96%
- AMPHBUYAmphastar Pharmaceuticals, Inc.$1.2BRECOVERYQ 9$26.62+0.12%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on AMRX?
- LOPJLB’s latest quantitative signal on Amneal Pharmaceuticals, Inc. (AMRX) is BUY in a BEAR regime. Signals are updated daily.
- What market regime is AMRX in?
- Amneal Pharmaceuticals, Inc. (AMRX) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Amneal Pharmaceuticals, Inc. (AMRX) do?
- Amneal Pharmaceuticals, Inc., operating alongside its various subsidiaries, is a diversified pharmaceutical company involved in the development, acquisition of licenses, manufacturing, marketing, and distribution of both generic and specialized medicinal products. These offerings span a multitude of delivery formats and target a wide range of therapeutic needs. Its operations are structured int…